Bill & Melinda Gates Foundation was founded in Seattle
In 2000, the Bill & Melinda Gates Foundation began as the William H. Gates Foundation established in 1994,…
Biotechnology | FDA | Oncology | Therapeutics
FDA approved Targretin to treat certain T-cell lymphomas
On Dec. 29, 1999, the U.S. Food and Drug Administration (FDA) approved Bexarotene (Targretin) to treat cutaneous T-cell…
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed
On Dec. 9, 1999, the diphtheria and tetanus toxoids and acellular pertussis vaccine (Tripedia by Connaught) was licensed….
The National Cancer Institute published Atlas of Cancer Mortality, 1950-94, showing geographic patterns of cancer death rates across U.S.
On Dec. 8, 1999, the National Cancer Institute published the Atlas of Cancer Mortality, 1950-94, showing the geographic…
The Genome Sequencing Center at Washington University – St Louis completed sequencing of one third of the human genome
On Dec. 2, 1999, an international team of researchers at the Sanger Centre near Cambridge, England; University of…
Alvin and Ruth Siteman donated $35 to establish the Siteman Cancer Center
On Dec. 2, 1999, Alvin and Ruth Siteman donated $35 million to establish the Alvin J. Siteman Cancer…
“To Err is Human” report published by the Institute of Medicine
On Nov. 29, 1999, the “To Err is Human” report was published by the Institute of Medicine, a…
The Bill & Melinda Gates Foundation pledged $750 million to establish the Global Fund for Children’s Vaccines
On Nov. 23, 1999, the Bill & Melinda Gates Foundation pledged a gift of $750 million over five…
Roche received FDA approval of TAMIFLU, first pill to treat most common strains of influenza (A&B)
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU (oseltamivir phosphate) had been approved…
Neuraminidase inhibitors Tamiflu and Relenza were licensed to treat influenza infection
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU™ (oseltamivir phosphate) has been approved…
Wyeth Lederle Vaccines voluntarily withdrew Rotashield from the market
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
The Institute for Systems Biology was founded in Seattle
On Oct. 12, 1999, the Institute for Systems Biology (ISB) was founded in Seattle by Alan Aderem, Ruedi…
The Buck Institute for Research on Aging opened its doors
On Sept. 30, 1999, the Buck Institute for Research on Aging, named for Marin County philanthropists Leonard and…
Dr. Ute Hochgeswender at the OMRF and Dr. Miles Brennan from the Eleanor Roosevelt institute designed genetically engineered mice
On Aug. 30, 1999, Dr. Ute Hochgeswender, Development Biology Research Program from the Oklahoma Medical Research Foundation (OMRF)…
The CDC identified and responded to West Nile Virus in New York City
In August 1999, an outbreak of encephalitis caused by West Nile virus (WNV) was detected in New York…
Gilead Sciences and NeXstar Pharmaceuticals announced completion of their merger
On Jul. 29, 1999, Gilead Sciences and NeXstar Pharmaceuticals announced the closing of their agreement whereby Gilead acquired…
The University of Southern California received a $110 million gift and was renamed the Keck School of Medicine
On Jul. 29, 1999, the University of Southern California (USC) announced that it had received a gift of…
BIO’99 in Seattle attracted more than 5,700 attendees with nearly thirty percent from outside the US
In Jul. 1999, the Biotechnology Industry Organization held BIO’99 in Seattle and the event attracted more than 5,700…
The Fitzsimons Redevelopment Authority was created
On Jun. 30, 1999, Fitzsimons Redevelopment Authority (FRA) announced that the former Fitzsimons Army Medical Center had been…
Biotechnology | CDC | Infectious Disease | Polio | Vaccine
ACIP recommended exclusive use of inactivated poliovirus vaccine (IPV) for infants and children
On Jun. 17, 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
The Dale and Betty Bumpers Vaccine Research Center was established
On Jun. 9, 1999, the Dale and Betty Bumpers Vaccine Research Center (VRC) was established at the National…
The Study of Tamoxifen and Raloxifene began recruiting volunteers
On May 25, 1999. the Study of Tamoxifen and Raloxifene, or STAR, one of the largest breast cancer…
George Rathmann was named the first recipient of the Biotechnology Heritage Award
On May 17, 1999, George Rathmann, Chair of Bothell-based ICOS Corp. and Chair Emeritus of Amgen, was named…
A pandemic planning framework was published by the World Health Organization
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
The Tennessee Biotechnology Association was established
On Apr. 15, 1999, the Tennessee Biotechnology Association (TBA), now the Life Science Tennessee, was established. The Tennessee…
ZymoGenetics was instrumental in development of new hemophilia drug
On Mar. 27, 1999, Novo Nordisk, the ZymoGenetics parent company, announced approval of NovoSeven by the Food and…
The Hybrid Capture II human papillomavirus (HPV) DNA test was approved by the FDA
On Mar. 17, 1999, the Hybrid Capture II human papillomavirus (HPV) DNA test was approved by the U.S….
Jane E Henney, MD, becomes the first woman Commissioner of Food and Drugs
On Jan. 17, 1999, Jane E. Henney, M.D., appointed by President Bill Clinton, became the first woman to…
Biotechnology | CDC | FDA | Infectious Disease | Vaccine
ACIP recommended DTaP vaccines for all five doses in the vaccination schedule
On Jan. 15. 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
The Carbone Cancer Center and McArdle Laboratories merged
In Jan. 1999, the Carbone Cancer Center and McArdle Laboratories merged and began to function as a single…